13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0000909661
Total reported value
$21.7B
$21.7B
144 檔
0.0%
The Q3 2025 SEC filing reveals that Farallon Capital Management, L.l.c. held a total portfolio value of $21.7B, covering 144 public equity positions.
In Q3 2025, Farallon Capital Management, L.l.c. displayed an active expansion posture, initiating 143 new positions and adding to 1 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ABVX | Abivax Sa-adr | Stock-Other | — | +0.08% | — | |
| 2 | AGIO | Agios Pharmaceuticals Inc | Stock-Other | — | -0.09% | — | |
| 3 | ANNA | Aleanna Inc | Stock-Other | — | — | — | |
| 4 | ANNAW | Aleanna Inc - Cl A - 29 | Stock-Other | — | — | — | |
| 5 | AEBA | Allete Inc | Stock-Other | — | — | — | |
| 6 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | — | — | — | |
| 7 | GOOG | Alphabet Inc-cl C | Stock-Comm Services | — | -1.63% | EXIT | |
| 8 | ALT | Altimmune Inc | Stock-Other | — | — | EXIT | |
| 9 | AMZN | Amazon.com Inc | Stock-Consumer Disc | — | -2.11% | — | |
| 10 | COR | Cencora Inc | Stock-Healthcare | — | — | EXIT | |
| 11 | AM6 | Amicus Therapeutics Inc | Stock-Other | — | — | EXIT | |
| 12 | ADI | Analog Devices Inc | Stock-Tech | — | — | — | |
| 13 | ARMK | Aramark | Stock-Industrials | — | -0.47% | — | |
| 14 | ACLXGBX | Arcellx Inc | Stock-Other | — | — | — | |
| 15 | ARDX | Ardelyx Inc | Stock-Other | — | — | EXIT | |
| 16 | ARQT | Arcutis Biotherapeutics Inc | Stock-Other | — | — | EXIT | |
| 17 | ARWR | Arrowhead Pharmaceuticals In | Stock-Healthcare | — | -0.01% | EXIT | |
| 18 | ASND | Ascendis Pharma A/S | Stock-Other | — | — | — | |
| 19 | ASMB | Assembly Biosciences Inc | Stock-Other | — | +0.01% | — | |
| 20 | ADSK | Autodesk Inc | Stock-Tech | — | — | — | |
| 21 | AXSM | Axsome Therapeutics Inc | Stock-Healthcare | — | — | EXIT | |
| 22 | BIDU | Baidu Inc - Spon Adr | Stock-Comm Services | — | +0.35% | — | |
| 23 | BEAM | Beam Therapeutics Inc | Stock-Other | — | +0.24% | — | |
| 24 | ONC | Beone Medicines Ltd-adr | Stock-Other | — | — | EXIT | |
| 25 | BBNX | Beta Bionics Inc | Stock-Other | — | -0.17% | — | |
| 26 | BYND | Beyond Meat Inc | Stock-Consumer Staples | — | — | — | |
| 27 | BCRX | Biocryst Pharmaceuticals Inc | Stock-Other | — | — | EXIT | |
| 28 | BSX | Boston Scientific CORP | Stock-Healthcare | — | -0.60% | — | |
| 29 | BBIO | Bridgebio Pharma Inc | Stock-Healthcare | — | -0.27% | — | |
| 30 | BTSG | Brightspring Health Services | Stock-Other | — | +0.17% | — | |
| 31 | CBRE | Cbre Group Inc - A | Stock-Real Estate | — | — | — | |
| 32 | CCCC | C4 Therapeutics Inc | Stock-Other | — | — | EXIT | |
| 33 | CGC | Canopy Growth CORP | Stock-Healthcare | — | — | — | |
| 34 | CAPR | Capricor Therapeutics Inc | Stock-Other | — | -0.01% | EXIT | |
| 35 | TVRD | Tvardi Therapeutics Inc | Stock-Other | — | — | EXIT | |
| 36 | CAH | Cardinal Health Inc | Stock-Healthcare | — | -0.44% | EXIT | |
| 37 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | — | -1.09% | EXIT | |
| 38 | CGON | Cg Oncology Inc | Stock-Other | — | -0.13% | — | |
| 39 | CDTX | Cidara Therapeutics Inc | Stock-Other | — | — | — | |
| 40 | COGT | Cogent Biosciences Inc | Stock-Other | — | — | — | |
| 41 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | — | -0.18% | — | |
| 42 | DIS | Walt Disney Co/the | Stock-Comm Services | — | -1.32% | EXIT | |
| 43 | DOCS | Doximity Inc-class A | Stock-Healthcare | — | — | — | |
| 44 | DYN | Dyne Therapeutics Inc | Stock-Other | — | — | EXIT | |
| 45 | ENTA | Enanta Pharmaceuticals Inc | Stock-Other | — | -0.05% | — | |
| 46 | EHC | Encompass Health CORP | Stock-Healthcare | — | — | EXIT | |
| 47 | EVH | Evolent Health Inc - A | Stock-Other | — | — | EXIT | |
| 48 | EXEL | Exelixis Inc | Stock-Healthcare | — | +0.17% | — | |
| 49 | GEHC | GE Healthcare Technology | Stock-Healthcare | — | — | EXIT | |
| 50 | GERN | Geron CORP | Stock-Other | — | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | KEL | Kellanova | -98.7% | +123.68% | Add |
| 2 | HYG | Ishr Ibx Usd Hiyld Cb Etf-ui | — | NEW | New buy |
| 3 | SPY | Ss Spdr S&p 500 ETF Trust-us | — | NEW | New buy |
| 4 | MSFT | Microsoft CORP | — | NEW | New buy |
| 5 | RSP | Invesco S&p 500 Equal Weight | — | NEW | New buy |
| 6 | AON | Aon plc | — | NEW | New buy |
| 7 | EXEL | Exelixis Inc | — | NEW | New buy |
| 8 | AMZN | Amazon.com Inc | — | NEW | New buy |
| 9 | NTRA | Natera Inc | — | NEW | New buy |
| 10 | RVMD | Revolution Medicines Inc | — | NEW | New buy |
| 11 | UNH | Unitedhealth Group Inc | — | NEW | New buy |
| 12 | TMO | Thermo Fisher Scientific Inc | — | NEW | New buy |
| 13 | HIMS | Hims & Hers Health Inc | — | NEW | New buy |
| 14 | DIS | Walt Disney Co/the | — | NEW | New buy |
| 15 | CRM | Salesforce Inc | — | NEW | New buy |
| 16 | ADSK | Autodesk Inc | — | NEW | New buy |
| 17 | BSX | Boston Scientific CORP | — | NEW | New buy |
| 18 | IBIT | Ishares Bitcoin Trust ETF | — | NEW | New buy |
| 19 | WAB | Wabtec CORP | — | NEW | New buy |
| 20 | BBIO | Bridgebio Pharma Inc | — | NEW | New buy |
| 21 | PTGX | Protagonist Therapeutics Inc | — | NEW | New buy |
| 22 | TRU | Transunion | — | NEW | New buy |
| 23 | ARMK | Aramark | — | NEW | New buy |
| 24 | INTU | Intuit Inc | — | NEW | New buy |
| 25 | NDAQ | Nasdaq Inc | — | NEW | New buy |
| 26 | ADI | Analog Devices Inc | — | NEW | New buy |
| 27 | SCHW | Schwab (charles) CORP | — | NEW | New buy |
| 28 | NYT | New York Times Co-a | — | NEW | New buy |
| 29 | LLY | Eli Lilly & Co | — | NEW | New buy |
| 30 | GOOG | Alphabet Inc-cl C | — | NEW | New buy |
| 31 | CBRE | Cbre Group Inc - A | — | NEW | New buy |
| 32 | MCK | Mckesson CORP | — | NEW | New buy |
| 33 | BEAM | Beam Therapeutics Inc | — | NEW | New buy |
| 34 | CRNX | Crinetics Pharmaceuticals In | — | NEW | New buy |
| 35 | ETHA | Ishares Ethereum Trust ETF | — | NEW | New buy |
| 36 | AGIO | Agios Pharmaceuticals Inc | — | NEW | New buy |
| 37 | V | Visa Inc-class A Shares | — | NEW | New buy |
| 38 | LQDA | Liquidia CORP | — | NEW | New buy |
| 39 | NSC | Norfolk Southern CORP | — | NEW | New buy |
| 40 | LNTH | Lantheus Holdings Inc | — | NEW | New buy |
| 41 | IQV | Iqvia Holdings Inc | — | NEW | New buy |
| 42 | WWD | Woodward Inc | — | NEW | New buy |
| 43 | MA | Mastercard Inc - A | — | NEW | New buy |
| 44 | 260 | Centessa Pharmaceuticals-adr | — | NEW | New buy |
| 45 | TEVA | Teva Pharmaceutical-sp Adr | — | NEW | New buy |
| 46 | TNGX | Tango Therapeutics Inc | — | NEW | New buy |
| 47 | BBNX | Beta Bionics Inc | — | NEW | New buy |
| 48 | THC | Tenet Healthcare CORP | — | NEW | New buy |
| 49 | GRAL | Grail Inc | — | NEW | New buy |
| 50 | EHC | Encompass Health CORP | — | NEW | New buy |
According to official SEC Form 13F filings, Farallon Capital Management, L.l.c. reported a total U.S. public equity portfolio value of $21.7B across 144 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ABVX, AGIO, ANNA) accounted for 0.0% of total reported equity market value during Q3 2025.
Top New Position Initiated
HYG
市值: $3.2B
During Q3 2025, Farallon Capital Management, L.l.c.'s top holdings by market value included ABVX (0.0%)、AGIO (0.0%)、ANNA (0.0%). The largest single position, ABVX, represented 0.0% of total portfolio value.
In Q3 2025, Farallon Capital Management, L.l.c. made 144 total portfolio adjustments, initiating 143 new buys, adding to 1 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.